|
Frequently Asked Questions
|
Create Your Account Now and Start Posting Resumes and/or Jobs
|
Create/Edit Your Resume
|
Search Jobs
|
Post Jobs, Search Resumes
|
|
|
|
Job Title: |
NCI T32 Postdoctoral Fellow
|
Job Number: |
|
Organization: |
Georgetown Lombardi Cancer Center
|
Posted: |
10/1/2024
|
Type: |
Full-Time
|
Classification: |
|
Industry: |
Academic Institutions
|
Number of Openings: |
1
|
Location: |
Washington DC, USA
|
Compensation: |
|
Position Description: |
The Georgetown Lombardi Comprehensive Cancer Center (GLCCC) is seeking outstanding candidates for an NCI-funded T32 postdoctoral training program in Cancer Population Science (CPaS). We are currently recruiting for Fall 2024 and Spring, Summer and Fall of 2025. The program focuses on preparing trainees for independent cancer research careers with a focus on clinical and community translational research. Training faculty have a wide breadth of domain- specific expertise with NIH-funded research programs in behavioral science, health disparities, cancer and aging, molecular epidemiology/biomarkers, health services/health policy, and survivorship in cancer populations. This includes research in tobacco control, cancer screening, cancer genetics, cancer energetics, global health, molecular tumor phenotypes, environment and cancer, supportive care interventions, and psychooncology. The program offers 2-3 years of funding, competitive salary and benefits, as well as funds for travel and research support.
GLCCC is the only National Cancer Institute- designated Comprehensive Cancer Center in the nation’s capital. Fellows participate in all phases of research, from study design through manuscript preparation, and participate in a formal didactic program. There also are opportunities to participate in multidisciplinary grant writing, the development of new projects, and to mentor undergraduate and graduate students. Additional opportunities for clinical training and supervision in psychooncology are available.
Highlights of the training environment of the CPaS Program include: › An established clinical consortium with access to the largest cancer population in the Mid-Atlantic › Georgetown Lombardi Institute for Cancer and Aging › A Minority Underserved NCORP site › The Ralph Lauren Center for Cancer Prevention › Two funded CISNET modeling groups › The Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research › The Georgetown-Howard Universities Center for Clinical and Translational Science › The McCourt School of Public Policy › The MedStar Health National Center for Human Factors in Healthcare
|
Qualifications: |
Applicants should have a PhD, MD, ScD, or DrPH in psychology, epidemiology, health services, or other related field with the goal of training in cancer-focused research. Open to U.S. citizens and permanent residents only. Previous experience conducting cancer-related research is desirable but not required. First-year trainee salary is $70,000.
|
Organization Description: |
Georgetown University is an Equal Opportunity, Affirmative Action employer fully dedicated to achieving a diverse faculty and staff. All qualified candidates are encouraged to apply and will receive consideration for employment without regard to race, sex, sexual orientation, age, religion, national origin, marital status, veteran status, disability or other categories protected by law.
|
Closing Date: |
5/1/2025
|
Desired Starting Date: |
|
|
Contact Name: |
Cancer Population Science Training Program, NCI T32 Postdoctoral Fellow
|
Contact Location: |
2115 Wisconsin Ave
Suite 300
Washington DC 20007
United States
|
Contact Location: |
2115 Wisconsin Ave
|
|
Suite 300
|
|
Washington DC 20007
|
|
United States
|
Contact Phone: |
|
Contact Fax: |
|
Contact Email: |
cpcpostdoctraining@georgetown.edu
|
Web Address: |
|
How to Apply: |
Program details and application can be found at: https://lombardi.georgetown.edu/education/cpas- program/
Direct additional questions to cpcpostdoctraining@georgetown.edu
|
Additional Information: |
|
Web Site Delete Date: |
3/30/2025
|
|
|
|